Patents Assigned to The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabe
-
Publication number: 20120149785Abstract: A method of estimating sepsis risk in an individual with infection comprises a step of assaying a biological sample from the individual for an IL-2 or IL-7 mRNA value, and correlating the mRNA value with sepsis risk. The IL-2 and IL-7 mRNA values are quantified by absolute quantification of mRNA copy number, wherein the copy numbers are normalised to a house keeping gene and corrected against a calibration curve for serial dilutions of the IL-2 and IL-7 cDNA. The method generally involves a step of assaying a biological sample from the individual for IL-2 and/or IL-7 mRNA values, optionally in combination with mRNA values for other cytokines, and correlating a sum or difference of the values with sepsis risk using a regression analysis curve against outcome.Type: ApplicationFiled: October 9, 2009Publication date: June 14, 2012Applicant: The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen ElizabeInventors: Thomas Ryan, Mary White, Owen Ross McManus, Dermot Kelleher
-
Publication number: 20110046182Abstract: Aspirin is one of the most widely used drugs in the treatment of inflammation, pain and fever. It has more recently found application in the prevention of heart attacks and stroke and is being studied as a cancer chemopreventative agent. Despite its value aspirin continues to be underutilized because it causes gastric bleeding. The technology under development potentially removes this problem. It is designed to reduce contact between the drug and the intestinal lining. An isosorbide aspirinate prodrug compound is thus provided. The compound has the general structure as shown in general formula (I) wherein Y is a C1-C8 alkyl ester, a C1-C8 alkoxy ester, a C3-C10 cycloalkyl ester, an arylester, a C1-C8 alkylaryl ester or —C(O)ORring, wherein Rring is a 5-membered aromatic or nonaromatic 5-member ring having at least one heteroatom substituted for a carbon of the ring system, which can be unsubstituted or substituted with at least one nitric oxide releasing group.Type: ApplicationFiled: December 19, 2008Publication date: February 24, 2011Applicant: The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen ElizabeInventors: John Francis Gilmer, Louise Clune-Moriarty, Maeve Lally
-
Publication number: 20100190841Abstract: The invention relates to gene suppression and replacement. In particular, the invention relates to enhanced expression of suppression agents for suppressing gene expression in a cell and in vivo and replacement nucleic acids that are not inhibited by the suppression agent. Regulatory elements are included in expression vectors to optimize expression of the suppression agent and/or replacement nucleic acid.Type: ApplicationFiled: April 14, 2008Publication date: July 29, 2010Applicant: THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABEInventors: Gwyneth Jane Farrar, Sophia Millington-Ward, Naomi Chadderton, Arpad Palfi, Mary O'Reilly, Paul Kenna, Peter Humphries
-
Publication number: 20100160332Abstract: The adrenergic receptors or adrenoceptors are a family of G-protein coupled receptors split into ? and ? subclasses. The adrenoceptors have important roles in regulating a myriad of physiological conditions and their malfunction has been implicated in the pathophysiology of a number of diseases. Disclosed herein are a series of novel compounds which are ligands of the alpha2-adrenoceptor (?2-ARs) subclass of adrenergic receptors. The invention also provides for pharmaceutical compositions comprising the novel compounds. The compounds are suitable for use in the manufacture of medicaments for the treatment of ?2-ARs associated disorders, such as depression and schizophrenia.Type: ApplicationFiled: December 22, 2009Publication date: June 24, 2010Applicant: The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen ElizabeInventors: Maria Isabel Rozas Hernando, Fernando Rodriguez Royo
-
Publication number: 20100088624Abstract: An animation tool which is configured to enable a user to generate one or more animations for subsequent execution on a computer platform is described. The animation tool provides a plurality of graphical integers which a user can use to generate an animation. The graphical integers are divisible into graphical elements and graphical element effects, the effects being applied by a user onto an element and defining the viewing properties of that element.Type: ApplicationFiled: October 3, 2008Publication date: April 8, 2010Applicants: The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabe, University College Cork-National University of IrelandInventors: James Bligh, Mark Tangney, Brendan Tangney, Chris Collins
-
Publication number: 20100046562Abstract: A tunable laser device (1) comprises integrally formed first and second ridge waveguides (5, 6). A longitudinally extending ridge (12) defines first and second light guiding regions (19, 20) of the first and second waveguides (5, 6) which communicate with each other. A plurality of first slots (27) extending laterally in the ridge (12) adjacent the first waveguide (5), and a plurality of second slots (28) extending laterally in the ridge (12) adjacent the second waveguide (6) produce first and second mirror loss spectra of the respective first and second waveguides (5, 6) with minimum peak values at respective first and second wavelength values.Type: ApplicationFiled: September 20, 2007Publication date: February 25, 2010Applicants: THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABE, UNIVERSITY COLLEGE PARK, NATIONAL UNIVERSITY OF IRELAND, CORKInventors: John F. Donegan, Richard Phelan, Wel-Hua Guo, Qiao-Yin Lu, Brian Corbett, Paul Martin Lambkin, Brendan John Roycroft
-
Publication number: 20100016224Abstract: The present invention relates to a method of enhancing a pro-inflammatory immune response through the administration of the DEAD-box protein DDX3, as encoded by SEQ ID NO:1. The invention further extends to a method of suppressing an aberrant immune response, such at that associated with autoimmune conditions, through inhibition of DDX3. The invention also extends to a method of suppressing a pro-inflammatory immune response through the administration of the vaccinia virus protein K7. The invention further extends to the provision of an attenuated poxvirus wherein the K7R gene which encodes for the K7 protein is deleted or rendered non-functional. Pharmaceutical compositions comprising DDX3 inhibitory compounds, such as K7, are also provided.Type: ApplicationFiled: August 27, 2007Publication date: January 21, 2010Applicant: The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen ElizabeInventors: Andrew Bowie, Martina Schroeder, Geoffrey Smith, Stuart Lucas
-
Publication number: 20070266892Abstract: The present invention describes a methods, uses, compositions such as adhesive, sealants and coatings, scaffold material, composite material, all comprising amyloid-like materials such as fibrils, in particular those made from fruit or vegetable proteins. The amyloid-like materials impart good mechanical strength to the materials in which it is employed. Inhibition of amyloid formation is also described.Type: ApplicationFiled: March 13, 2007Publication date: November 22, 2007Applicant: The Provost, Fellows and Scholars of the College of The Holy and Undivided Trinity of Queen ElizabeInventors: Suzanne Jarvis, Anika Mostaert